Selected Publications
Editorial: Functional implications of Piwi proteins and piRNAs in stem cell maintenance and development.
O'Sullivan FLA, Das AV and Rojas-Rí os P (2025)
Front. Cell Dev. Biol. doi: 10.3389/fcell.2025.1583955.
MicroRNA-532-3p Modulates Colorectal Cancer Cell Proliferation and Invasion via Suppression of FOXM1.
Mahajan K, Das AV, Alahari SK, Pothuraju R, Nair SA. (2024)
Cancers (Basel) doi: 10.3390/cancers16173061.
HPV16 E6/E7-mediated regulation of PiwiL1 expression induces tumorigenesis in cervical cancer cells.
Kunnummal M, Raveendran PS, Basu B, Rani SV, Paul RA, Kuppusamy K, Angelin M, Issac J, James J, Das AV. (2023)
Cellular Oncology doi: 10.1007/s13402-023-00904-8.
RXR agonist, Bexarotene, effectively reduces drug resistance via regulation of RFX1 in embryonic carcinoma cells.
Issac J, Raveendran PS, Midhunaraj K, Angelin M, Swathy R, Basu B, Das AV (2023)
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research doi.org/10.1016/j.bbamcr.2023.119510
HES1 promoter activation dynamics reveal the plasticity, stemness and heterogeneity in neuroblastoma cancer stem cells.
Riya PA, Basu B, Surya S, Parvathy S, Lalitha S, Jyothi NP, Meera V, Jaikumar VS, Sunitha P, Shahina A, Sukumaran R, Nair AS, Dhanesh SB, Jiffy J, Nelson-Sati S, Maliekal TT, Das AV, James J. (2022)
Journal of Cell Science doi: 10.1242/jcs.260157
PIWI proteins and piRNAs in cervical cancer: a propitious dart in cancer stem cell-targeted therapy.
Kunnummal M, Angelin M, Das AV (2021)
Human Cell doi: 10.1007/s13577-021-00590-4
RFX1: a promising therapeutic arsenal against cancer.
Issac J, Raveendran PS, Das AV (2021)
Cancer Cell International doi: 10.1186/s12935-021-01952-6.